herpes zoster pain, post herpetic neuralgia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who were administered TCAs for herpes zoster pain or post herpetic neuralgia between May 2007 and January 2012, and who have electrocardiogram before and after the medication.
Exclusion criteria
Exclusion criteria: Patients who were administered other antipsychotic or anti-arrhythmic agents, and who have any rhythm disturbance on the electrocardiogram (ECG) before medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QTc interval before and after the administration of TCAs. | — |
Secondary
| Measure | Time frame |
|---|---|
| age, gender, the type and dose of administered TCAs, medication periods | — |
Countries
Japan
Contacts
Osaka City University Graduate School of Medicine Anesthesiology